American Lithium
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Just sent to JT:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Biobillionair Member Profile
Member Level 
Followed By 98
Posts 14,475
Boards Moderated 0
Alias Born 01/12/13
160x600 placeholder
Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws Business Wire - 2/22/2019 6:18:00 PM
Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019 GlobeNewswire Inc. - 2/19/2019 6:00:00 AM
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire Inc. - 2/14/2019 6:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 4:35:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/8/2019 4:33:41 PM
New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American Colleg... GlobeNewswire Inc. - 1/23/2019 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2019 4:43:20 PM
Amarin Provides Preliminary 2018 Results and 2019 Outlook GlobeNewswire Inc. - 1/4/2019 4:15:00 PM
Amarin to Present at 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 GlobeNewswire Inc. - 1/2/2019 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2018 6:35:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2018 6:34:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2018 4:08:05 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 11/29/2018 3:07:20 PM
Amarin to Participate in a Fireside Chat at Citi’s 2018 Global Healthcare Conference GlobeNewswire Inc. - 11/28/2018 6:25:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/28/2018 5:24:09 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 11/26/2018 8:59:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/26/2018 5:32:33 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 11/26/2018 4:23:58 PM
Amarin to Present at the Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/20/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/14/2018 6:03:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 6:18:24 AM
Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stro... PR Newswire (US) - 11/11/2018 10:32:00 AM
Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stro... GlobeNewswire Inc. - 11/10/2018 3:00:00 PM
Amarin to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire Inc. - 11/8/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2018 4:13:25 PM
Biobillionair Member Level  Tuesday, 02/12/19 09:33:51 AM
Re: None
Post # of 177272 
Just sent to JT:

Quote:
Hi John-

Just in case you haven’t seen the warning letters the FDA has recently sent, here’s a link: https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm630564.htm

Specifically relevant to Amarin and Vascepa quote:

On the webpage titled, “Omega 3 Benefits Stroke – Fish Oil Supplement May Help”:
Fish oil supplements have been shown to have anti-inflammatory effects in diseases such as cancer, asthma, rheumatoid arthritis, osteoporosis, dry eye disease, age-related macular degeneration, coronary heart disease and sepsis.”
“The use of fish oil supplements as a protective factor against stroke and other neurological diseases such as Alzheimer’s has been suggested.”


Hopefully we see the Federal Circuit Court FINALLY publish their ITC opinion, but the above should be reassuring from a legal stance the sNDA for REDUCE-IT won’t be used and abused by the supplement industry.

I look forward to watching you bring this home, and great job with the recent execution of raising cash and hiring sales. If the FDA doesn’t grant an accelerated approval I will obviously lose my shit, but there’s no blaming Amarin, you’ve put up a great fight.

Keep up the good work and please send a thank you to your leadership team.

Best Regards,

Jason



I have no information regarding when an sNDA will be filed, but it's one symbolic message if Amarin deliveries it Thursday 2-14-2019.

BB

I do not pump Amarin stock. I am not an Amarin cheerleader. If I see something I don't like I make it known. Patients come first, always!!!
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist